0000914208-15-000229.txt : 20150210 0000914208-15-000229.hdr.sgml : 20150210 20150210171019 ACCESSION NUMBER: 0000914208-15-000229 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20150210 DATE AS OF CHANGE: 20150210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-57907 FILM NUMBER: 15594833 BUSINESS ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Invesco Ltd. CENTRAL INDEX KEY: 0000914208 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 980557567 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-892-0896 MAIL ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd DATE OF NAME CHANGE: 20080508 FORMER COMPANY: FORMER CONFORMED NAME: Invesco PLC DATE OF NAME CHANGE: 20080429 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd. DATE OF NAME CHANGE: 20071205 SC 13G 1 biodeliverysciinte12312014.htm BIODELIVERY SCIENCES INTERNATIONAL, INC 12312014 biodeliverysciinte12312014.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(b) AND
AMENDMENTS FILED THERETO FILED PURSUANT TO RULE 13D-2(b)
 
Under the Securities Exchange Act of 1934
(Amendment No. _)*
 
BioDelivery Sciences International, Inc.
 (Name of Issuer)

Common Stock
(Title of Classes of Securities)
 
09060J106
(CUSIP Number)

December 31, 2014
(Date of Event Which Requires Filing of this Statement)
 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
: X       Rule 13d-1(b)
:           Rule 13d-1(c)
:           Rule 13d-1(d)


 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

 

CUSIP No.: 09060J106
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
 
Invesco Ltd.
IRS # 980557567
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Invesco Ltd. – Bermuda
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5
 
SOLE VOTING POWER – 3,061,431
 
 
6
 
SHARED VOTING POWER – 0
 
 
7
 
SOLE DISPOSITIVE POWER – 3,061,431
 
 
8
 
SHARED DISPOSITIVE POWER – 0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,061,431
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
N/A
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
    6.0%
12
TYPE OF REPORTING PERSON*
 
    See Item 3 of this statement

 

 

Item 1(a). Name of Issuer:
 
BioDelivery Sciences International, Inc.

(b). Address of Issuer’s Principal Executive Offices:
 
801 Corporate Center Drive; Suite 210; Raleigh, NC 27607; United States
 
Item 2(a). Name of Person Filing:
 
Invesco Ltd.
 
(b). Address of Principal Business Office or, if none, residence of filing person:
 
1555 Peachtree Street NE; Atlanta, GA 30309; United States
 
(c). Citizenship of filing person:
 
Bermuda
 
(d). Title of Classes of Securities:
 
Common Stock

(e). CUSIP Number:
 
09060J106

Item 3. If this statement is filed pursuant to ss240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
(e) [x] An investment adviser in accordance with section 240.13d-1(b)(1)(ii)(E)

(g) [x] A parent holding company or control person in accordance with section 240.13d-1(b)(1)(ii)(G)

Item 4. Ownership:

Please see responses to Items 5-8 on the cover of this statement, which are incorporated herein by reference.

Item 5. Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]

Item 6. Ownership of More than Five Percent on Behalf of Another Person:

Invesco Powershares Capital Management is a subsidiary of Invesco Ltd. and it advises Invesco Powershares Dynamic Pharmaceuticals Portfolio which owns 5.97% of the security reported herein. However no one individual has greater than 5% economic ownership. The shareholders of the Fund have the right to receive or the power to direct the receipt of dividends and proceeds from the sale of securities listed above.

 

 

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:

The following subsidiary of Invesco Ltd. is an investment adviser which holds shares of the security being reported:

Invesco PowerShares Capital Management

Item 8. Identification and Classification of Members of the Group:

N/A

Item 9. Notice of Dissolution of a Group:

N/A

Item 10. Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signature:

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

02/02/2015
Date

Invesco Ltd.

By:          /s/ Lisa Brinkley
Lisa Brinkley
Global Assurance Officer
EX-99 2 jfa12312014.htm JOINT FILING AGREEMENT 12312014 jfa12312014.htm
JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd., as the ultimate parent company of each of its undersigned subsidiaries, to file such Schedule 13G, and any and all amendments thereto, on behalf of each of them.

Dated: 12/31/2014


Invesco Ltd.

By: /s/ Lisa Brinkley
Name: Lisa Brinkley
Title: Global Assurance Officer


Invesco Advisers, Inc.

By: /s/ Todd L. Spillane
Name: Todd L. Spillane
Title: Chief Compliance Officer


Invesco Canada Ltd.

By: /s/ Daniela Nalli
Name: Daniela Nalli
Title: Chief Compliance Officer


Invesco Trust Company

By: /s/ Kevin Lyman
Name: Kevin Lyman
Title: General Counsel


Invesco Hong Kong Limited

By: /s/ Asha Balachandra
Name: Asha Balachandra
Title: Reg. Head of Legal AP


Invesco Asset Management Deutschland GmbH

By: /s/ Stephanie Ehrenfried
Name: Stephanie Ehrenfried
Title: Head of Legal Continental Europe & Cross-Border Funds
 

Invesco Asset Management Limited

By: /s/ Ross Maclean
Name: Ross Maclean
Title: Director of UK Compliance


Invesco Asset Management S.A.

By: /s/ Matthieu Grosclaude
Name: Matthieu Grosclaude
Title: Deputy-CEO, Invesco Asset Management S.A


Invesco Asset Management S.A.

By: /s/ Bemard Aybran
Name: Bernard Aybran
Title: Deputy-CEO


Invesco Asset Management Osterreich GmbH

By: /s/ Thomas Kraus
Name: Thomas Kraus
Title: Head of Institutional Business D-A-CH


Invesco Management S.A.

By: /s/ Marie-Hélène Boulanger
Name: Marie-Hélène Boulanger
Title: Head of Risk Governance


Invesco Taiwan Limited

By: /s/ Asha Balachandra
Name: Asha Balachandra
Title: Reg. Head of Legal, AP


Invesco Asset Management (Japan) Limited

By: /s/ Asha Balachandra
Name: Asha Balachandra
Title: Reg. Head of Legal, AP


Invesco Asset Management Singapore Limited

By: /s/ ­ Asha Balachandra
Name: Asha Balachandra
Title: Reg. Head of Legal, AP

 
Invesco Global Asset Management Limited

By: /s/ Cormac O’Sullivan
Name: Cormac O'Sullivan
Title: Head of PMO, EU


Invesco PowerShares Capital Management

By: /s/ Deanna Marotz
Name: Deanna Marotz
Title: Chief Compliance Officer


Invesco Investment Advisers, LLC

By: /s/ Jesse Frazier
Name: Jesse Frazier
Title: Chief Compliance Officer


Invesco Australia Ltd.

By: /s/ Jane Stewart
Name: Jane Stewart
Title: Compliance Manager